# Cancer Control Research Program

> **NIH NIH P30** · UNIVERSITY OF PENNSYLVANIA · 2020 · $77,523

## Abstract

Project Summary 
The Cancer Control Program is one of two Population Science Research Programs of the Abramson Cancer 
Center (ACC).The transdisciplinary program composed of 27 members who focus on the identification of the 
genetic, behavioral and health care determinants of cancer susceptibility and the development and 
implementation of strategies to lower risk and improve outcomes. The Program is directly concerned with 
improving cancer outcomes in the ACC's catchment area and working inter-Programmatically with all Research 
Programs to apply advances in science to the health of populations. The members of the Program seek to 
improve population health across the cancer spectrum through advancing science in the areas of: 1) Risk 
Assessment; 2) Survivorship; 3) Communication and Health Behavior; and 4) Health Outcomes. The Program 
has produced a substantial body of high impact work in the current project period. In the area of Risk 
Assessment, members have led multiple groundbreaking studies which established the basis for clinical 
management of women with BRCA1/2 mutations, identified risk loci associated with susceptibility to testicular 
germ cell tumor and established genetic and genomic predictors of response to therapy in melanoma. In the 
area of Survivorship, members have set clinical paradigms for cancer survivors through establishing care plans 
and demonstrating that exercise programs improve outcomes. In the area of Communication and Health 
Behavior, members are national leaders in health messaging and behavioral economics, with innovative 
studies on use of incentives for improving health behaviors. In the area of Health Outcomes, members lead 
critically important multidisciplinary studies on how research advances are translated into clinical practice and 
address health care disparities within the ACC catchment area. The Program recruited 13 members in the 
project period, with particularly important recruits in the area of ethical, legal and social implications of genetic 
testing (Dr. Joffe), health communication and brain activity (Dr. Falk) and population-based cancer prevention 
(Dr. Doubeni). The Program works closely with the Tobacco Environmental and Carcinogenesis Program to 
create a robust population science initiative with widespread inter- and intra-Programmatic collaborative efforts. 
Members of the Program come from nine departments within the Perelman School of Medicine, the School of 
Nursing, the Wharton School of Business, and the Annenberg School of Communication. Exemplifying the 
robust collaborative nature of the research environment, there have been 544 cancer-related publications over 
the project period. Of these, 13% are intra-Programmatic, 37% are inter-Programmatic and 78% are multi- 
institutional. Further demonstrating the substantive productivity of these collaborations, members have $11.5M 
in annual cancer-related research grant funding (annual direct costs), of which $9.9M is peer-review...

## Key facts

- **NIH application ID:** 9836834
- **Project number:** 5P30CA016520-44
- **Recipient organization:** UNIVERSITY OF PENNSYLVANIA
- **Principal Investigator:** Karen Glanz
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $77,523
- **Award type:** 5
- **Project period:** — → —

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9836834

## Citation

> US National Institutes of Health, RePORTER application 9836834, Cancer Control Research Program (5P30CA016520-44). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/9836834. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*